ProfileGDS5678 / 1446235_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 41% 42% 42% 43% 43% 40% 40% 42% 41% 43% 42% 43% 49% 42% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.9785841
GSM967853U87-EV human glioblastoma xenograft - Control 22.9746642
GSM967854U87-EV human glioblastoma xenograft - Control 32.9735742
GSM967855U87-EV human glioblastoma xenograft - Control 42.9491643
GSM967856U87-EV human glioblastoma xenograft - Control 52.9431643
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.9954240
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.9747940
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.9651442
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.9222241
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.9681843
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.9621642
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.9607343
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 43.1662649
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.9656142